[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Propedix, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100611829","phase-2-topical-tolnaftate-stick-for-tinea-pedis-an-open-label-interventional-study-100611829",false,"NCT07245667","Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study","Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis","Inclusion Criteria:\n\n* Male or female, aged 16 or above\n* Clinical diagnosis of tinea pedis (For Cohort 4, positive symptomology is acceptable)\n* Confirmation of diagnosis with positive potassium hydroxide (KOH) microscopy (For Cohort 4, a negative KOH test is acceptable)\n* Signed and dated informed consent form\n* Willingness to comply with study protocol and availability for the duration of the study\n\nExclusion Criteria:\n\n* Diagnosis of moccasin-type tinea pedis\n* Presence of serous exudate or pus\n* Treatment with a topical antifungal in the past 2 weeks\n* Treatment with a systemic antifungal in the past 4 weeks\n* Concurrent immunosuppressive or antimicrobial therapy\n* Liver disease\n* Pregnancy or breastfeeding\n* Use any other antifungal therapy during trial or within three months of starting the trial\n* Known hypersensitivity to any ingredients of trial agents\n* Patients with a current diagnosis of diabetes or neuropathy",true,"ALL","16 Years",{"count":20,"type":21},150,"ESTIMATED","INTERVENTIONAL",[24],"PHASE2","This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).",[27],"Tinea Pedis",[29,30],"tinea pedis","athletes foot","RECRUITING","2025-11-23",{"date":34,"type":35},"2025-11-28","ACTUAL",{"date":37,"type":35},"2024-12-30",{"date":39,"type":21},"2026-02",{"name":41,"class":42},"Propedix, Inc.","INDUSTRY",2,""]